Literature DB >> 3335222

Use of fluorescent dyes as molecular probes for the study of multidrug resistance.

A A Neyfakh1.   

Abstract

Fluorescence microscopy has shown that 18 different fluorescent dyes, staining various intracellular structures in transformed hamster fibroblasts (DM-15), did not stain or stained weakly multidrug-resistant cells selected from DM-15 by colchicine. Reduced staining by fluorescent dyes was characteristic also of five other tested multidrug-resistant cell lines of hamster and mouse origin, selected by actinomycin D, colcemid, rubomycin, and ruboxyl. The intensity of staining of two revertant cell lines was similar to that of parental sensitive cells. All tested inhibitors of multidrug resistance, including weak detergent, metabolic inhibitors, calcium channel blockers, calmodulin inhibitors, and reserpine, restored normal staining of multidrug-resistant cells. The dyes accumulated in resistant cells in presence of these inhibitors left the cells several minutes after the removal of the inhibitor from the incubation medium. Sensitive cells retained the dyes for several hours. The efflux of the dyes from resistant cells is an active process since it occurred even in the presence of the dyes in the incubation medium. The efflux could be blocked by all tested inhibitors of multidrug resistance and it is possibly a basic mechanism of the reduced staining of resistant cells. These data support the idea that multidrug resistance is based on active nonspecific efflux of the drugs and indicate that the simple procedure of cell staining can be used for the detection of resistant cells and further study of the phenomenon of multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335222     DOI: 10.1016/0014-4827(88)90152-8

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  37 in total

1.  Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles.

Authors:  Ivan Manzini; Detlev Schild
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

2.  Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine.

Authors:  J Hofmann; A Wolf; M Spitaler; G Böck; J Drach; C Ludescher; H Grunicke
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

4.  Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro.

Authors:  A M Al-Abd; A M Mahmoud; G A El-Sherbiny; M A El-Moselhy; S M Nofal; H A El-Latif; W I El-Eraky; H A El-Shemy
Journal:  Cell Prolif       Date:  2011-10-20       Impact factor: 6.831

5.  Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.

Authors:  Tariq Shah; Flonne Wildes; Marie-France Penet; Paul T Winnard; Kristine Glunde; Dmitri Artemov; Ellen Ackerstaff; Barjor Gimi; Samata Kakkad; Venu Raman; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2010-07       Impact factor: 4.044

6.  In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury.

Authors:  Andrew M Hall; George J Rhodes; Ruben M Sandoval; Peter R Corridon; Bruce A Molitoris
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

7.  Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.

Authors:  E B Mechetner; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Albumin uptake in OK cells exposed to rotenone: a model for studying the effects of mitochondrial dysfunction on endocytosis in the proximal tubule?

Authors:  A M Hall; M Campanella; A Loesch; M R Duchen; R J Unwin
Journal:  Nephron Physiol       Date:  2010-05-13

9.  BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

Authors:  E C de Lange; G de Bock; A H Schinkel; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

10.  Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

Authors:  Emma Morrish; Anthony Copeland; Donia M Moujalled; Jason A Powell; Natasha Silke; Ann Lin; Kate E Jarman; Jarrod J Sandow; Gregor Ebert; Liana Mackiewicz; Jessica A Beach; Elizabeth L Christie; Alexander C Lewis; Giovanna Pomilio; Karla C Fischer; Laura MacPherson; David D L Bowtell; Andrew I Webb; Marc Pellegrini; Mark A Dawson; Stuart M Pitson; Andrew H Wei; John Silke; Gabriela Brumatti
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.